DK1150662T3 - Laminater indeholdende aktivt stof til transdermale systemer - Google Patents

Laminater indeholdende aktivt stof til transdermale systemer

Info

Publication number
DK1150662T3
DK1150662T3 DK00907516T DK00907516T DK1150662T3 DK 1150662 T3 DK1150662 T3 DK 1150662T3 DK 00907516 T DK00907516 T DK 00907516T DK 00907516 T DK00907516 T DK 00907516T DK 1150662 T3 DK1150662 T3 DK 1150662T3
Authority
DK
Denmark
Prior art keywords
active substance
containing active
transdermal systems
sex hormone
laminates containing
Prior art date
Application number
DK00907516T
Other languages
English (en)
Inventor
Detlef Grawe
Peter Hoesel
Wilfried Fischer
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK1150662T3 publication Critical patent/DK1150662T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
DK00907516T 1999-02-10 2000-02-08 Laminater indeholdende aktivt stof til transdermale systemer DK1150662T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19906152A DE19906152B4 (de) 1999-02-10 1999-02-10 Wirkstoffhaltige Laminate für Transdermalsysteme
PCT/EP2000/000983 WO2000047191A1 (de) 1999-02-10 2000-02-08 Wirkstoffhaltige laminate für transdermalsysteme

Publications (1)

Publication Number Publication Date
DK1150662T3 true DK1150662T3 (da) 2004-01-26

Family

ID=7897479

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00907516T DK1150662T3 (da) 1999-02-10 2000-02-08 Laminater indeholdende aktivt stof til transdermale systemer

Country Status (11)

Country Link
US (1) US6902741B1 (da)
EP (1) EP1150662B1 (da)
JP (1) JP4132679B2 (da)
AT (1) ATE249818T1 (da)
AU (1) AU2908000A (da)
CA (1) CA2372710C (da)
DE (2) DE19906152B4 (da)
DK (1) DK1150662T3 (da)
ES (1) ES2207488T3 (da)
PT (1) PT1150662E (da)
WO (1) WO2000047191A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0116793B8 (pt) * 2000-12-14 2021-05-25 Johnson & Johnson produtos de hormônio de esteróide e métodos para prepará-los
EA009024B1 (ru) 2002-06-25 2007-10-26 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Фармацевтическая композиция для чрескожной доставки активного агента (варианты)
AU2004212675B2 (en) 2003-02-21 2006-06-01 Bayer Intellectual Property Gmbh UV stable transdermal therapeutic plaster
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
DE10348046A1 (de) * 2003-10-16 2005-05-19 Beiersdorf Ag Verfahren zur Herstellung von Matrizes für transdermale oder topicale Wirkstoffsysteme
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
JP4965263B2 (ja) * 2003-12-12 2012-07-04 バイエル ファーマ アクチエンゲゼルシャフト 浸透増強剤を必要としないホルモンの経皮送達
DE102004016779A1 (de) * 2004-04-01 2006-01-19 Schering Ag Drospirenonhaltige Zubereitungen zur transdermalen Anwendung
US20080138390A1 (en) * 2004-04-07 2008-06-12 Tsung-Min Hsu Transdermal Delivery System For Use With Basic Permeation Enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
CN102091079B (zh) * 2005-06-03 2014-03-12 艾克若克斯Dds有限公司 用于透皮给药的方法和组合物
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
KR101301116B1 (ko) 2007-01-11 2013-09-03 애크럭스 디디에스 피티와이 리미티드 분산 기구
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2111857A1 (de) * 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
AU2009262871B2 (en) * 2008-05-30 2016-04-14 Mylan Inc. Stabilized transdermal drug delivery system
KR20110082142A (ko) 2008-10-06 2011-07-18 밀란 테크놀로지즈 인코포레이티드 비정질 로티고틴 경피 시스템
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
HUE031326T2 (hu) * 2010-09-06 2017-07-28 Bayer Ip Gmbh Alacsony dózisú transzdermális tapaszok magas hatóanyagleadással
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
JP6757351B2 (ja) 2017-04-28 2020-09-16 日東電工株式会社 経皮吸収型製剤
WO2022212529A1 (en) * 2021-03-30 2022-10-06 Viatris Inc. Transdermal systems having low dose estrogen and methods of making and use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
JPS6193112A (ja) * 1984-06-15 1986-05-12 Sekisui Chem Co Ltd 貼付剤
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5232703A (en) * 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
IT1250421B (it) 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
DE4332284C2 (de) 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4334553C2 (de) 1993-10-11 1998-05-20 Synopharm Gmbh Pharmazeutische Flüssiges pharmazeutisches System zur perkutanen Applikation
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
JPH10306023A (ja) * 1997-05-06 1998-11-17 Sekisui Chem Co Ltd 経皮吸収製剤及びその製造方法
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
US6312715B1 (en) * 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition

Also Published As

Publication number Publication date
ES2207488T3 (es) 2004-06-01
JP4132679B2 (ja) 2008-08-13
DE19906152A1 (de) 2000-08-17
DE50003721D1 (de) 2003-10-23
CA2372710C (en) 2006-04-11
DE19906152B4 (de) 2005-02-10
EP1150662B1 (de) 2003-09-17
ATE249818T1 (de) 2003-10-15
EP1150662A1 (de) 2001-11-07
JP2002536403A (ja) 2002-10-29
CA2372710A1 (en) 2000-08-17
PT1150662E (pt) 2004-02-27
US6902741B1 (en) 2005-06-07
AU2908000A (en) 2000-08-29
WO2000047191A1 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
DK1150662T3 (da) Laminater indeholdende aktivt stof til transdermale systemer
CA1272954A (en) Ph-mediated drug delivery system
KR100628796B1 (ko) 에스트라디올과 다른 스테로이드를 함께 투여하기 위한 경피약물 송달기제
AU679794B2 (en) Monoglyceride/lactate ester permeation enhancer for oxybutynin
HRP20050828B1 (hr) Uv-stabilni transdermalni flaster
SE9803871D0 (sv) Therapeutic method and formulation
FI960556A0 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
IL160515A0 (en) Transdermal therapeutic system (tts) with fentanyl as active ingredient
DK1691851T3 (da) Sårplaster og fremgangsmåder
BRPI0507683A (pt) dose unitária com liberação de formulação farmacêutica com liberação controlada, processo para sua preparação, bem como uso de um copolìmero de poli(acrilato de etila, metacrilato de metila) neutro
DK1021204T3 (da) Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
PT80865B (pt) Dispositivo de libertacao de um principio activo
NO974194L (no) Forbedringer i, eller vedrörende, organiske sammensetninger
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
FR2801507B1 (fr) Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
BR9908910A (pt) Sistema terapêutico transdérmico (tts) para a administração transcutânea de oxibutinina e método para sua preparação
DK1152751T3 (da) Transdermalt, terapeutisk desoxypeganinsysstem
NL192780B (nl) Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof.
DK1284718T3 (da) Okklusivt transdermalt terapeutisk system med et ikke-okklusivt baglag
WO2005046600A3 (en) Transdermal tulobuterol delivery
ATE340567T1 (de) Transdermales therapeutisches system zur verabreichung des partiellen dopamin-d2-agonisten aripiprazol
CA3175771A1 (en) Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquine
ATE20311T1 (de) Polymerische diffusionsmatritze propranolol enthaltend.
CA2370023A1 (en) Transdermal therapeutic system with a highly effective neuroleptic agent
BR0001923A (pt) Estação de comutação de rádio e método para distribuir chamadas